ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

IPA ImmunoPrecise Antibodies Ltd

1.26
-0.02 (-1.56%)
取引時間後
最終更新日: 05:00:04
15分遅延
名称 銘柄コード 市場 種別
ImmunoPrecise Antibodies Ltd IPA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.02 -1.56% 1.26 05:00:04
始値 安値 高値 終値 前日終値
1.26 1.26 1.32 1.26 1.28
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/2903:35BWInterSystems et BioStrand, filiale d’IPA, collaborent au..
2024/3/2820:02BWInterSystems and IPA’s Subsidiary BioStrand Collaborate to..
2024/3/2102:52BWIPA acquiert l'instrument Carterra LSA® pour améliorer la..
2024/3/2020:02BWIPA Acquires the Carterra LSA® Instrument to Enhance..
2024/3/1508:39BWIPA présente ses résultats financiers et les récents points..
2024/3/1421:05BWIPA Reports Financial Results and Recent Business Highlights..
2024/3/0805:24BWBioStrand, filiale d'IPA, annonce une avancée majeure dans..
2024/3/0801:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/3/0721:02BWIPA’s subsidiary BioStrand Unveils Major Breakthrough in..
2024/3/0506:50BWL'IPA publiera ses résultats financiers et les faits..
2024/3/0422:01BWIPA to Report Financial Results and Recent Business..
2024/2/2407:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/2407:26EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/1605:12EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
2024/1/1103:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/1103:33EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/12/1505:08BWIPA présente ses résultats financiers et les récents points..
2023/12/1422:48EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/1422:38EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/1422:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/1422:01BWIPA Reports Financial Results and Recent Business Highlights..
2023/12/0911:57BWIPA annonce la clôture d'une offre publique d'actions..
2023/12/0907:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/0907:00BWIPA Announces Closing of $1.265 Million Public Offering of..
2023/12/0806:53EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/12/0707:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/0621:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/0621:00BWIPA annonce le prix des actions ordinaires de son émission..
2023/12/0620:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/0610:22BWIPA annonce une proposition d'offre publique d'actions..
2023/12/0606:35BWIPA Announces Proposed Public Offering of Common Shares
2023/12/0606:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/2803:09BWImmunoPrecise Antibodies Ltd annonce des nominations clés au..
2023/11/2722:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/2722:01BWImmunoPrecise Antibodies Ltd. Announces Key Board and Board..
2023/11/1707:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/1404:09BWBioStrand® dévoile une approche révolutionnaire de la..
2023/11/1322:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/1322:32BWBioStrand® Unveils a Revolutionary Approach to Biological..
2023/10/2601:12BWBioStrand, filiale de l'IPA, fait le point sur LENSai™
2023/10/2521:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/2521:01BWIPA’s Subsidiary, BioStrand, Provides an Update on LENSai™
2023/10/2402:36BWIPA apporte une mise à jour sur sa stratégie de croissance..
2023/10/2321:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/2321:01BWIPA Provides Update on Growth Strategy and Recent Share..
2023/10/2103:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/2700:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/2605:46EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/2001:34BWImmunoPrecise Antibodies annonce le remplacement de son..
2023/9/1921:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

最近閲覧した銘柄

Delayed Upgrade Clock